Back to top
more

Henry Schein (HSIC)

(Real Time Quote from BATS)

$65.73 USD

65.73
409,297

-0.54 (-0.82%)

Updated Jun 14, 2024 03:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 28% (179 out of 249)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Henry Schein to Offer CAS' Fully-Automated Cognivue Device

by Zacks Equity Research

Henry Schein (HSIC) is consistently working toward boosting its Medical segment.

    Henry Schein MicroMD Software Gets ONC-Health IT Certificate

    by Zacks Equity Research

    Henry Schein's (HSIC) MicroMD receives ONC-Health IT Certificate from Drummond Group, boosting the company's technology and value-added service business.

      Henry Schein Joins IMF & LUGFA on Prostate Cancer Awareness

      by Zacks Equity Research

      Henry Schein (HSIC) joins forces with IMF and LUGPA to generate awareness among physicians and people about the importance of early detection of prostate cancer.

        Henry Schein's Merritt Buyout to Boost U.S. Veterinary Arm

        by Zacks Equity Research

        Henry Schein's (HSIC) acquisition of Merritt Veterinary supplies will brace its existing U.S. animal health business, particularly in the southeastern United States.

          Henry Schein to Offer CAEK's HIPAA Software LayerCompliance

          by Zacks Equity Research

          Henry Schein (HSIC) inks an agreement to distribute CAEK's HIPAA related software, LayerCompliance.

            Henry Schein (HSIC) Q2 Earnings & Revenues Beat, View Intact

            by Zacks Equity Research

            Henry Schein (HSIC) maintained its stellar performance in Q2 as well, courtesy of strength in all of its business segments.

              Henry Schein (HSIC) Tops Q2 Earnings and Revenues Estimate

              by Zacks Equity Research

              Henry Schein (HSIC) rides high on all four segments in Q2 delivered solid earnings growth on back of the strategy to grow the business organically and through acquisitions.

                Med-Product Stocks Aug 8 Earnings Roster: HSIC, AGIO & More

                by Zacks Equity Research

                Long-term tailwinds including M&A, emerging markets, positive demographic trends and new product innovation might bode well for the medical device industry.

                  Can Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?

                  by Zacks Equity Research

                  The timing of Good Friday is likely to dampen sales at Henry Schein (HSIC) in second-quarter 2017. Meanwhile, geographic expansion should continue.

                    Here's Why Henry Schein is Worth Adding to Your Portfolio

                    by Zacks Equity Research

                    Over the last six months, Henry Schein Inc. (HSIC) was consistently trading ahead of the S&P 500 Index.

                      Henry Schein Grows on Strategic Buyouts, Competition Rife

                      by Zacks Equity Research

                      On Jun 15, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).

                        Henry Schein (HSIC) Up 5.3% Since Earnings Report: Can It Continue?

                        by Zacks Equity Research

                        Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                          Henry Schein (HSIC) Rides on Global Growth, Strategic Deals

                          by Zacks Equity Research

                          On May 25 2017, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).

                            Pure Storage (PSTG) Posts Narrower-than-Expected Q1 Loss

                            by Zacks Equity Research

                            Pure Storage Inc. (PSTG) reported non-GAAP loss (including stock-based compensation) of 30 cents per share in the first-quarter of fiscal 2018, which was narrower than the Zacks Consensus Estimate by 8 cents.

                              Henry Schein (HSIC) Tops Q1 Earnings, Reaffirms '17 View

                              by Zacks Equity Research

                              Henry Schein, Inc. (HSIC) reported adjusted earnings per share (EPS) of $1.76 in the first quarter of 2017, up 24.8% year over year.

                                Henry Schein (HSIC) Tops Q1 Earnings and Revenues Estimate

                                by Zacks Equity Research

                                Headquartered in Melville, NY, Henry Schein Inc. (HSIC) is a global leading provider of healthcare products and services.

                                  Medical Product Q1 Earnings Due on May 9: XRAY, HSIC & More

                                  by Zacks Equity Research

                                  Medical product, an important part of the medical device subcategory within the broader Medical sector, looks promising at the moment.

                                    Will Henry Schein (HSIC) Deliver a Surprise in Q1 Earnings?

                                    by Zacks Equity Research

                                    Henry Schein, Inc. (HSIC) is expected to report first-quarter 2017 results on May 2, before the opening bell.

                                      Henry Schein (HSIC) Poised on Solid Growth, Risks Remain

                                      by Zacks Equity Research

                                      On Mar 27, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).

                                        Henry Schein Inks Agreement for Rijuven's CardioSleeve

                                        by Zacks Equity Research

                                        Henry Schein, Inc. (HSIC) recently signed an exclusive distribution agreement with patient care platform designer Rijuven Corp. to sell the latter's CardioSleeve device

                                          Henry Schein (HSIC) Tops Q4 Earnings, Reaffirms '17 View

                                          by Zacks Equity Research

                                          Henry Schein, Inc. (HSIC) reported adjusted earnings per share of $1.88 in the fourth quarter of 2016, up 12.6% year over year and surpassed the Zacks Consensus Estimate by 2.2%.

                                            Henry Schein (HSIC) Tops Q4 Earnings and Revenues Estimates

                                            by Zacks Equity Research

                                            Henry Schein (HSIC) reported positive fourth quarter 2016 results with earnings and sales exceeding the Zacks Consensus Estimate.

                                              Henry Schein to Acquire SAS to Strengthen Dental Offerings

                                              by Zacks Equity Research

                                              Henry Schein Inc. (HSIC) announced its decision to acquire Southern Anesthesia + Surgical (SAS).

                                                MedTech Stocks Earnings Slated on Feb 21: MDT, HSIC and More

                                                by Zacks Equity Research

                                                Let's take a look at the major MedTech stocks slated to release their Oct-Dec 2016 numbers on Feb 21.

                                                  Henry Schein (HSIC) Q4 Earnings: Disappointment in Store?

                                                  by Zacks Equity Research

                                                  Henry Schein, Inc. (HSIC) is expected to report fourth-quarter 2016 financial numbers on Feb 8, before the opening bell.